Nutrien: The Downtrend Is Done, Dividend Hike And Technicals Are Evidence
Nutrien offers value with an attractive yield, improved Q4 performance, and bullish technical signals. Read why I have a buy rating on NTR stock.
Wells Fargo & Company Issues Positive Forecast for Nutrien (NYSE:NTR) Stock Price
Nutrien (NYSE:NTR – Free Report) had its price target increased by Wells Fargo & Company from $53.00 to $56.00 in a research ...
Analysts’ Opinions Are Mixed on These Materials Stocks: Nutrien (NTR), Mercer International (MERC) and Ecolab (ECL)
Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Nutrien (NTR – Research Report), Mercer ...
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Canadian Press on MSN45m
Tariff talk: What corporate Canada is saying during earnings season
As companies report their earnings for the latest quarter, they’ve fielded question after question from analysts about how ...
Zacks.com on MSN5h
ICL Group Rallies 31% in 3 Months: Time to Snap Up the Stock?
ICL Group Ltd’s ICL shares have rallied 31% in the past three months, significantly outperforming the Zacks Fertilizers ...
Nike To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Monday
Mizuho cut Intra-Cellular Therapies, Inc. ITCI price target from $140 to $132. Mizuho analyst Graig Suvannavejh downgraded the stock from Outperform to Neutral. Intra-Cellular Therapies shares closed ...